Trials / Completed
CompletedNCT00082576
Azithromycin Plus Chloroquine Versus Mefloquine for the Treatment of Uncomplicated Malaria in Africa
A Phase II/III, Randomized, Double-Blind, Comparative Trial Of Azithromycin Plus Chloroquine Versus Mefloquine For The Treatment Of Uncomplicated Plasmodium Falciparum Malaria In Africa
- Status
- Completed
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 238 (actual)
- Sponsor
- Pfizer · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The primary objective is to confirm the hypothesis that azithromycin plus chloroquine is non-inferior to mefloquine for the treatment of symptomatic, uncomplicated malaria due to P. falciparum.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Azithromycin/Chloroquine | |
| DRUG | Mefloquine |
Timeline
- Start date
- 2004-06-01
- Completion
- 2006-05-01
- First posted
- 2004-05-14
- Last updated
- 2011-05-11
Locations
6 sites across 4 countries: Ghana, Mali, Uganda, Zambia
Source: ClinicalTrials.gov record NCT00082576. Inclusion in this directory is not an endorsement.